Global Substance Abuse Treatment Market to Grow at a CAGR of 5.15% By 2021 - Key Vendors are Alkermes, Allergan, GSK & Pfizer - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Substance Abuse Treatment Market 2017-2021" report to their offering.

The global substance abuse treatment market to grow at a CAGR of 5.15% during the period 2017-2021.

This report, Global Substance Abuse Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion operating in this market.

The latest trend gaining momentum in the market is consolidation of rehabilitation centers. In the last decade, rehabilitation centers have increasingly adopted inorganic growth strategies. Acquisition of smaller rehabilitation centers by the major rehab centers across the globe have led to a uniformity in treatment patterns, increased capacity of major rehabilitation centers, and presence across various regions. Many of the smaller mental rehabilitation centers have been acquired and have expanded their functionality to include treatment for substance abuse.

According to the report, one of the major drivers for this market is multiple facets of treatment. Substance abuse is a complex condition and involves every aspect of an individual's functioning, namely family, work/school, and the community. Therefore, a substance abuse treatment involves multiple components, where some are focused on re-establishing an individual as a productive member of the family and community. This approach is to enable an individual to recognize the benefits of a life without substance abuse.

Key vendors:

  • Alkermes
  • Allergan
  • GSK
  • Pfizer

Other prominent vendors:

  • Accord Healthcare
  • Amphastar Pharmaceuticals
  • Apotex
  • BioCorRx
  • Cipla
  • Glenmark
  • INSYS Therapeutics
  • LFB Group
  • Lupin
  • Others

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope of the report

Part 03: Research Methodology

Part 04: Introduction

Part 05: An overview of diseases related to substance abuse

Part 06: Market landscape

Part 07: Segmentation by type of abuse

Part 08: Geographical segmentation

Part 09: Decision framework

Part 10: Drivers and challenges

Part 11: Market trends

Part 12: Vendor landscape

Part 13: Key vendor analysis

For more information about this report visit https://www.researchandmarkets.com/research/hznl9t/global_substance

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Addiction Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Addiction Disorders Drugs